Prognostic and Theranostic Biomarkers in Ovarian Clear Cell Carcinoma.
Wiedemeyer K, Wang L, Kang EY, Liu S, Ou Y, Kelemen LE, Feil L, Anglesio MS, Glaze S, Ghatage P, Nelson GS, Köbel M.
Int J Gynecol Pathol. 2022 Mar 1;41(2):168-179. doi: 10.1097/PGP.0000000000000780.
CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.
Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y, Dai Y, Sun F, Yang C, Huang Y, Yang J, Tang Y, Han Y, He M, Zhang Y, Song L, Xia JC.
J Immunother Cancer. 2022 Mar;10(3):e004029. doi: 10.1136/jitc-2021-004029.
'STIC-like' lesions in ovarian low-grade serous carcinoma: a diagnostic pitfall.
Machuca-Aguado J, McCluggage WG.
Histopathology. 2023 Sep;83(3):489-492. doi: 10.1111/his.14967. Epub 2023 Jun 25.
Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma.
Daisuke H, Kato H, Fukumura K, Mayeda A, Miyagi Y, Seiki M, Koshikawa N.
Cancer Sci. 2021 Dec;112(12):4957-4967. doi: 10.1111/cas.15149. Epub 2021 Nov 5.
The role of the fallopian tube in the origin of ovarian cancer.
Erickson BK, Conner MG, Landen CN Jr.
Am J Obstet Gynecol. 2013 Nov;209(5):409-14. doi: 10.1016/j.ajog.2013.04.019. Epub 2013 Apr 10.
Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.
Jiang RT, Yemelyanova A, Xing D, Anchoori RK, Hamazaki J, Murata S, Seidman JD, Wang TL, Roden RBS.
J Ovarian Res. 2017 Aug 7;10(1):53. doi: 10.1186/s13048-017-0347-y.
Prognostic value of ALK overexpression and molecular abnormalities in high-grade serous ovarian carcinoma.
Gorczyński A, Miszewski K, Gager Y, Koch S, Pötschke J, Ugrinovski D, Gabert J, Pospieszyńska A, Wydra D, Duchnowska R, Szymanowski B, Cierniak S, Kruecken I, Neumann K, Mirkov K, Biernat W, Czapiewski P.
Cancer Biomark. 2023;38(1):17-26. doi: 10.3233/CBM-230117.
Loss of ovarian function promotes angiogenesis in human ovarian carcinoma.
Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E, Neeman M.
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13203-8. doi: 10.1073/pnas.94.24.13203.
Amplification of 11q13 in ovarian carcinoma.
Brown LA, Kalloger SE, Miller MA, Shih IeM, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB, Huntsman DG.
Genes Chromosomes Cancer. 2008 Jun;47(6):481-9. doi: 10.1002/gcc.20549.
Circular RNA Foxo3 enhances progression of ovarian carcinoma cells.
Wang L, Chen J, Lu C.
Aging (Albany NY). 2021 Sep 23;13(18):22432-22443. doi: 10.18632/aging.203550. Epub 2021 Sep 23.
